Azenta ( AZTA ) Q3 EPS Jumps 36%
Azenta ( NASDAQ:AZTA ) , a provider of life sciences solutions focusing on sample management and genomics services, released its third-quarter fiscal 2025 results on August 5, 2025. The headline: Non-GAAP profitability beat expectations, but GAAP revenue was flat and missed analyst forecasts.
Is the Options Market Predicting a Spike in Azenta ( AZTA ) Stock?
Investors need to pay close attention to Azenta (AZTA) stock based on the movements in the options market lately.
Azenta ( AZTA ) Surges 7.2%: Is This an Indication of Further Gains?
Azenta (AZTA) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Williams-Sonoma, Wix.com, Dolby Laboratories And Other Big Stocks Moving Higher On Wednesday - Azenta ( NASDAQ:AZTA ) , Alignment Healthcare ( NASDAQ:ALHC )
U.S. stocks were lower, with the Nasdaq Composite falling more than 200 points on Wednesday. Shares of Williams-Sonoma, Inc. WSM rose sharply during Wednesday's session after the company reported better-than-expected third-quarter financial results.
Flex Set to Join S&P MidCap 400; Azenta and Concentra Group Holdings to Join S&P SmallCap 600 - Concentra Group Holdings ( NYSE:CON ) , Azenta ( NASDAQ:AZTA )
NEW YORK, Nov. 19, 2024 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P MidCap 400 and S&P SmallCap 600: Flex Ltd FLEX will replace Azenta Inc. AZTA in the S&P MidCap 400, and Azenta will replace Envestnet Inc.
Biobanking Market to Reach Market Valuation of USD 95.5 Billion by 2031 | SkyQuest Technology
Westford, USA, Nov. 13, 2024 ( GLOBE NEWSWIRE ) -- SkyQuest projects that the global biobanking market will reach a value of USD 95.5 Billion by 2031, with a CAGR of 6.8% during the forecast period ( 2024-2031 ) .
Azenta ( AZTA ) Q4 Earnings Top Estimates
Brooks (AZTA) delivered earnings and revenue surprises of 63.64% and 0.26%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
IRhythm Technologies ( IRTC ) Reports Q3 Loss, Tops Revenue Estimates
iRhythm Technologies (IRTC) delivered earnings and revenue surprises of -129.09% and 0.17%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Azenta ( AZTA ) Q3 Earnings and Revenues Top Estimates
Brooks (AZTA) delivered earnings and revenue surprises of 128.57% and 4.26%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Enovis ( ENOV ) to Report a Decline in Earnings: What to Look Out for
Enovis (ENOV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Analysts Estimate Azenta ( AZTA ) to Report a Decline in Earnings: What to Look Out for
Brooks (AZTA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Is the Options Market Predicting a Spike in Azenta ( AZTA ) Stock?
Investors need to pay close attention to Azenta (AZTA) stock based on the movements in the options market lately.
FinnGen Selects Azenta to Propel Personalized Medicine for Population Health Study - Azenta ( NASDAQ:AZTA )
Azenta will provide proteomics technology profiling on up to 20,000 individuals. BURLINGTON, Mass., July 22, 2024 /PRNewswire/ -- Azenta, Inc. AZTA today announced its participation in the FinnGen project, a large-scale research initiative at the forefront of personalized medicine in Finland.
Hyperfine ( HYPR ) to Release ACTION PMR Study Data for Swoop
Hyperfine (HYPR) is set to release study data in August 2024, showing the value of the Swoop system in enabling critical stroke treatment choices in urgent care settings.
New Strong Buy Stocks for July 16th
BTG, APOG, AZTA, AFYA and KGC have been added to the Zacks Rank #1 (Strong Buy) List on July 16, 2024.
10x Genomics ( TXG ) Surges 8.2%: Is This an Indication of Further Gains?
10x Genomics (TXG) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
RFID Blood Refrigerator and Freezer Market size is set to grow by USD 498.3 million from 2024-2028, High demand for ... - PR Newswire
RFID Blood Refrigerator and Freezer Market size is set to grow by USD 498.3 million from 2024-2028, High demand for ... PR ...
Medical Facility Environmental Monitoring System Market size is set to grow by USD 114.3 million from 2024-2028 ... - PR Newswire
Medical Facility Environmental Monitoring System Market size is set to grow by USD 114.3 million from 2024-2028 ... PR ...
DNA Sequencing Market size is set to grow by USD 17.34 billion from 2024-2028, Growing adoption of ngs to boost the ... - PR Newswire
DNA Sequencing Market size is set to grow by USD 17.34 billion from 2024-2028, Growing adoption of ngs to boost the ... PR ...
Oligonucleotide Synthesis Market is Expected to Reach $19.7 billion | MarketsandMarkets™
Chicago, May 15, 2024 ( GLOBE NEWSWIRE ) -- Oligonucleotide Synthesis market in terms of revenue was estimated to be worth $8.8 billion in 2024 and is poised to reach $19.7 billion by 2029, growing at a CAGR of 17.5% from 2024 to 2029 according to a latest report published by MarketsandMarkets™.
Bioinformatics Market size is set to grow by USD 8535.52 mn from 2023-2027, reduction in cost of genetic sequencing ... - PR Newswire
Bioinformatics Market size is set to grow by USD 8535.52 mn from 2023-2027, reduction in cost of genetic sequencing ... PR ...
Azenta Announces CEO Succession Plan
BURLINGTON, Mass., May 8, 2024 /PRNewswire/ -- Azenta, Inc. ( Nasdaq: AZTA ) today announced a CEO succession plan, under which CEO and Board Director Dr. Stephen Schwartz will be retiring from Azenta after more than 14 years of service.
Fulgent Genetics, Inc. ( FLGT ) Reports Q1 Loss, Misses Revenue Estimates
Fulgent Genetics (FLGT) delivered earnings and revenue surprises of 96.97% and 1.90%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Cryogenic Freezers Market size to grow by USD 148.21 million from 2022 to 2027, Technavio - PR Newswire
Cryogenic Freezers Market size to grow by USD 148.21 million from 2022 to 2027, Technavio PR ...
Global Tissue Banking Market to Exhibit Growth at a Considerable CAGR of ~6% by 2030, Assesses DelveInsight
The tissue banking market is experiencing a surge in demand due to several factors: the growing prevalence and occurrence of chronic illnesses, the expanding elderly population susceptible to such ailments, and the potential breakthroughs in treating cancers, blood disorders, immune conditions, ...
IBD Rating Upgrades: Azenta Flashes Improved Price Strength
In a welcome move, Azenta ( AZTA ) saw its Relative Strength Rating rise from 68 to 71 on Thursday. X This exclusive rating from Investor's Business Daily identifies price action with a 1 ( worst ) to 99 ( best ) score.
Azenta Shows Rising Relative Price Performance; Still Shy Of Key Benchmark
Azenta Shows Rising Relative Price Performance. Still Shy Of Key Benchmark Investor's Business Daily ...
Inspire Medical Systems ( INSP ) Surpasses Q4 Earnings and Revenue Estimates
Inspire (INSP) delivered earnings and revenue surprises of 1,325% and 0.05%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Outset Medical, Inc. ( OM ) Expected to Beat Earnings Estimates: Should You Buy?
Outset Medical, Inc. (OM) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Hims & Hers Health, Inc. ( HIMS ) Moves 8.3% Higher: Will This Strength Last?
Hims & Hers Health, Inc. (HIMS) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Crispr Surges After Winning The First CRISPR Gene-Editing Approval
In a world first, regulators in the UK approved Crispr Therapeutics' ( CRSP ) gene-editing treatment for two blood diseases on Thursday. CRSP stock surged on the news. The drug formerly known as exa-cel will sell under the brand name Casgevy following the approval.
Top 2% Biotech Breaks Out On $285 Million Gilead Tie-Up
ACLX Stock Breaks Out After Inking A $285 Million Deal With ... Investor's Business Daily ...
3 Stocks to Watch After Impressive Earnings Beats
In a somewhat quiet earnings lineup this week, several stocks stand out after posting strong quarterly results on Monday.
Biotech Stock Flies 15% After Dodging A Proxy Battle
AZTA Stock Surges. Azenta Dodges A Proxy Battle With Activist Investor's Business Daily ...
Azenta Reports Upbeat Earnings, Joins Talis Biomedical, Sally Beauty And Other Big Stocks Moving Higher On Tuesday - Adaptive Biotechnologies ( NASDAQ:ADPT ) , Accolade ( NASDAQ:ACCD )
U.S. stocks traded higher, with the Dow Jones gaining around 500 points on Tuesday. Shares of Azenta, Inc. AZTA rose on Tuesday after the company reported better-than-expected fourth-quarter financial results. Azenta posted adjusted earnings of 13 cents per share, beating market estimates of 2 ...
Stock movers: Snapchat, Theseus Pharmaceuticals, Azenta, Beauty Health, Fisker
Shares in Snapachat, Theseus Pharmaceuticals,Azenta, Beauty Health, and Fisker were all active in pre market trading ...
Azenta makes board changes, takes other steps; avoids proxy fight with activist
Azenta makes board changes, takes other steps. avoids proxy fight with activist ...
Azenta Shows Rising Relative Price Performance; Still Shy Of Key Benchmark
Azenta Shows Rising Relative Price Performance. Still Shy Of Key ... Investor's Business Daily ...
The Next Generation Sequencing Market to grow at a CAGR of 12.45% from 2022 to 2027|10X Genomics Inc., Azenta ... - PR Newswire
The Next Generation Sequencing Market to grow at a CAGR of 12.45% from 2022 to 2027|10X Genomics Inc., Azenta ... PR ...
Azenta Clears Technical Benchmark, Hitting 80-Plus RS Rating
One important metric to look for in a stock is an 80 or higher Relative Strength Rating. Azenta ( AZTA ) now clears that threshold, with a jump from 78 to 83 Friday. X When looking for the best stocks to buy and watch, one factor to watch closely is relative price strength.
The Next Generation Sequencing Market to grow at a CAGR of 12.45% from 2022 to 2027|10X Genomics Inc., Azenta ... - PR Newswire
The Next Generation Sequencing Market to grow at a CAGR of 12.45% from 2022 to 2027|10X Genomics Inc., Azenta ... PR ...
You Can't Control Activist Investors, but You Can Control What You Do About Them
Activist investors come after companies both big and small, usually looking to get management to change their ways.
Stocks With Rising Relative Price Strength: Azenta
Azenta ( AZTA ) saw a welcome improvement to its Relative Strength ( RS ) Rating on Wednesday, with an upgrade from 79 to 83. X When looking for the best stocks to buy and watch, one factor to watch closely is relative price strength.
Activist Politan Capital engages with Azenta. Here's how the firm may boost shareholder value
Azenta is sitting on a pile of cash, and shareholders will want to know the company's plans for the money.
Azenta Stock Getting Closer To Key Technical Measure
Azenta ( AZTA ) stock saw a positive improvement to its Relative Strength ( RS ) Rating on Friday, rising from 67 to 73. When looking for the best stocks to buy and watch, keep a close on eye on relative price strength.
Azenta Getting Closer To Key Technical Measure
Azenta ( AZTA ) saw a positive improvement to its Relative Strength ( RS ) Rating on Friday, rising from 67 to 73. X When looking for the best stocks to buy and watch, keep a close on eye on relative price strength.
Azenta Announces CFO Transition
BURLINGTON, Mass., Sept. 26, 2023 /PRNewswire/ -- Azenta, Inc. ( Nasdaq: AZTA ) today announced that Herman Cueto will join Azenta as Executive Vice President and Chief Financial Officer, effective October 16.
Activist investor Politan Capital increases ownership in Azenta -filing
Activist investor Politan Capital increases ownership in ...
Cryocooler Market to grow by USD 816.44 million from 2022 to 2027 | Increasing adoption of cryopreservation ... - PR Newswire
Cryocooler Market to grow by USD 816.44 million from 2022 to 2027 | Increasing adoption of cryopreservation ... PR ...
iSpecimen Launches New Virtual Cancer Sequencing Procurement Program - iSpecimen ( NASDAQ:ISPC )
Program to Provide Cancer Researchers with Direct Access to Highly Sought Donor Tumor Tissue Samples Virtual Inventory Comprised of Formalin-Fixed, Paraffin-Embedded ( FFPE ) Samples Screened for Mutations LEXINGTON, Mass., Aug. 30, 2023 ( GLOBE NEWSWIRE ) -- iSpecimen Inc.
